PRMT4 promotes hepatocellular carcinoma progression by activating AKT/mTOR signaling and indicates poor prognosis: Erratum

Detalles Bibliográficos
Autores principales: Du, Peng, Luo, Kaifeng, Li, Guoyong, Zhu, Jisheng, Xiao, Qi, Li, Yong, Zhang, Xingjian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2022
Materias:
Erratum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964328/
https://www.ncbi.nlm.nih.gov/pubmed/35370468
http://dx.doi.org/10.7150/ijms.71614
_version_ 1784678190992588800
author Du, Peng
Luo, Kaifeng
Li, Guoyong
Zhu, Jisheng
Xiao, Qi
Li, Yong
Zhang, Xingjian
author_facet Du, Peng
Luo, Kaifeng
Li, Guoyong
Zhu, Jisheng
Xiao, Qi
Li, Yong
Zhang, Xingjian
author_sort Du, Peng
collection PubMed
description
format Online
Article
Text
id pubmed-8964328
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Ivyspring International Publisher
record_format MEDLINE/PubMed
spelling pubmed-89643282022-03-31 PRMT4 promotes hepatocellular carcinoma progression by activating AKT/mTOR signaling and indicates poor prognosis: Erratum Du, Peng Luo, Kaifeng Li, Guoyong Zhu, Jisheng Xiao, Qi Li, Yong Zhang, Xingjian Int J Med Sci Erratum Ivyspring International Publisher 2022-03-03 /pmc/articles/PMC8964328/ /pubmed/35370468 http://dx.doi.org/10.7150/ijms.71614 Text en © The author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
spellingShingle Erratum
Du, Peng
Luo, Kaifeng
Li, Guoyong
Zhu, Jisheng
Xiao, Qi
Li, Yong
Zhang, Xingjian
PRMT4 promotes hepatocellular carcinoma progression by activating AKT/mTOR signaling and indicates poor prognosis: Erratum
title PRMT4 promotes hepatocellular carcinoma progression by activating AKT/mTOR signaling and indicates poor prognosis: Erratum
title_full PRMT4 promotes hepatocellular carcinoma progression by activating AKT/mTOR signaling and indicates poor prognosis: Erratum
title_fullStr PRMT4 promotes hepatocellular carcinoma progression by activating AKT/mTOR signaling and indicates poor prognosis: Erratum
title_full_unstemmed PRMT4 promotes hepatocellular carcinoma progression by activating AKT/mTOR signaling and indicates poor prognosis: Erratum
title_short PRMT4 promotes hepatocellular carcinoma progression by activating AKT/mTOR signaling and indicates poor prognosis: Erratum
title_sort prmt4 promotes hepatocellular carcinoma progression by activating akt/mtor signaling and indicates poor prognosis: erratum
topic Erratum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964328/
https://www.ncbi.nlm.nih.gov/pubmed/35370468
http://dx.doi.org/10.7150/ijms.71614
work_keys_str_mv AT dupeng prmt4promoteshepatocellularcarcinomaprogressionbyactivatingaktmtorsignalingandindicatespoorprognosiserratum
AT luokaifeng prmt4promoteshepatocellularcarcinomaprogressionbyactivatingaktmtorsignalingandindicatespoorprognosiserratum
AT liguoyong prmt4promoteshepatocellularcarcinomaprogressionbyactivatingaktmtorsignalingandindicatespoorprognosiserratum
AT zhujisheng prmt4promoteshepatocellularcarcinomaprogressionbyactivatingaktmtorsignalingandindicatespoorprognosiserratum
AT xiaoqi prmt4promoteshepatocellularcarcinomaprogressionbyactivatingaktmtorsignalingandindicatespoorprognosiserratum
AT liyong prmt4promoteshepatocellularcarcinomaprogressionbyactivatingaktmtorsignalingandindicatespoorprognosiserratum
AT zhangxingjian prmt4promoteshepatocellularcarcinomaprogressionbyactivatingaktmtorsignalingandindicatespoorprognosiserratum

Ejemplares similares